Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population.
Measles is a highly infectious disease that has been targeted for elimination from four WHO regions. Whether and under which conditions this goal is feasible is, however, uncertain since outbreaks have been documented in populations with high vaccination coverage (more than 90%). Here, we use the example of a large outbreak in a German public school to show how estimates of key epidemiological parameters such as the basic reproduction number (R(0)), vaccine efficacy (VE(S)) and critical vaccination coverage (p(c)) can be obtained from partially observed outbreaks in highly vaccinated populations. Our analyses rely on Bayesian methods of inference based on the final size distribution of outbreak size, and use data which are easily collected. For the German public school the analyses indicate that the basic reproduction number of measles is higher than previously thought (R(0) = 30.8, 95% credible interval: 23.6-40.4), that the vaccine is highly effective in preventing infection (VE(S) = 0.997, 95% credible interval: 0.993-0.999), and that a vaccination coverage in excess of 95 per cent may be necessary to achieve herd immunity (p(c) = 0.971, 95% credible interval: 0.961-0.978). We discuss the implications for measles elimination from highly vaccinated populations.
van Boven
Michiel
M
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. michiel.van.boven@rivm.nl
Kretzschmar
Mirjam
M
Wallinga
Jacco
J
O'Neill
Philip D
PD
Wichmann
Ole
O
Hahné
Susan
S
D001499:Bayes Theorem; D003198:Computer Simulation; D004196:Disease Outbreaks / Q000517:prevention & control*; D005858:Germany; D006801:Humans; D032521:Immunity, Herd; D016013:Likelihood Functions; D008457:Measles / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D008458:Measles Vaccine; D012189:Retrospective Studies; D012574:Schools; D016896:Treatment Outcome; D014611:Vaccination
D008458:Measles Vaccine
Bull World Health Organ. 2009 Feb;87(2):108-15
19274362
Vaccine. 2003 Jun 2;21(19-20):2643-50
12744901
Biometrics. 2003 Sep;59(3):467-75
14601747
Bull World Health Organ. 1985;63(6):1055-68
3879673
Pediatr Infect Dis J. 2007 Sep;26(9):782-6
17721371
J Infect Dis. 2004 May 1;189 Suppl 1:S86-90
15106095
PLoS Comput Biol. 2007 Jul;3(7):e145
17676981
Lancet. 2009 Jan 31;373(9661):383-9
19131097
CMAJ. 1996 Nov 15;155(10):1407-13
8943928
Pediatrics. 2005 Dec;116(6):1287-91
16322148
Singapore Med J. 2007 Jul;48(7):656-61
17609829
J R Soc Interface. 2010 Feb 6;7(43):271-83
19535416
Am J Epidemiol. 2008 Dec 15;168(12):1343-52
18974084
PLoS Med. 2005 Nov;2(11):e316
16218769
Am J Epidemiol. 1998 Dec 1;148(11):1103-10
9850133